Overview

Comparison of Efficacy and Safety Psoralen Combined With Ultraviolet A (PUVA) Vs Tofacitinib in the Treatment of Generalized Vitiligo.

Status:
NOT_YET_RECRUITING
Trial end date:
2026-05-31
Target enrollment:
Participant gender:
Summary
This study aims to compare the efficacy and safety of PUVA versus Tofacitinib in the treatment of generalized vitiligo. Given the high prevalence of vitiligo in Pakistan and the significant psychosocial impact on patients, particularly in Peshawar, this study will provide valuable insights into optimal treatment strategies.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Hayat Abad Medical Complex, Peshawar.